Abstract
Combining multiple drugs into a single dosage form could have benefits for patients with heart disease, according to recent research published in JAMA by Anubha Agarwal, MD, and colleagues. The researchers described a polypill-based strategy for patients who have heart failure with reduced ejection fraction (HFrEF).
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
